1 October 2025

Dermatology PBS pharmaceutical

‘Unsustainable’: Pfizer pulls out of JAKi PBS application

9 July 2025

Hidradenitis Suppurativa PBS

PBS recommendations for bimekizumab, guselkumab

30 April 2025

PBS

New authority requirement adding to the PBS ‘clickfest’

5 March 2025

PBS psoriatic arthritis

Risankizumab added to PBS for psoriatic arthritis

10 July 2024

PBS

‘Breakthough’ as first targeted lupus drug hits PBS

21 February 2024

PBS

Dermatology patients to benefit from PBAC outcomes

21 February 2024

PBS Public Health

PBS tapentadol dispensing declines

7 February 2024

Melanoma PBS

Melanoma drug newly listed on PBS

2 November 2023

Paediatrics PBS pharmaceutical

PBS cuts etanercept red tape

18 October 2023

PBS Vaccination

Almost 5m Aussies to benefit from Shingrix listing

23 August 2023

PBS pharmaceutical

Shingrix to be funded from 1 November

3 May 2023

PBS Vaccination

Shingrix greenlit for immune compromised over-18s

26 October 2022

PBS

‘Life-changing’ treatment wins PBS approval

11 October 2022

Atopic Dermatitis Drugs PBS TGA

New hope for itchy kids

28 September 2022

PBS Political

NPS MedicineWise confirms time’s up

31 August 2022

PBS Political

NPS MedicineWise funding faces the chop